Loading the company…
Loading the company…
No clearances or recalls under the mapped product codes.
All companies · Product and company coverage
In 2025, Fusion Orthopedics reported engagement with 34 surgeons and other clinicians in the states MedaRep covers, worth $89K in consulting, speaking, meals and travel for its device products, the most in California ($15K to 5). Royalties are left out.
Spend tied to a procedure counts the payments whose product names it. Open Payments shows the payments companies reported. It suggests engagement, not which devices a surgeon uses, and is not evidence of wrongdoing.Top states by spend: California ($15K, 5 engaged), Ohio ($14K, 3 engaged), Kentucky ($14K, 3 engaged), Illinois ($11K, 4 engaged), Arizona ($8,675, 4 engaged).
In the last ten years FDA made 12 decisions for Fusion Orthopedics (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 0 procedure families, the most in 2019 (3). The latest was on 2026-03-18.
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Fusion Orthopedics.